Vaccines 2021, 9(3), 210; https://doi.org/10.3390/vaccines9030210 - 03 Mar 2021
Best Paper Award
Dear Colleagues,
We are pleased to announce the “Vaccines 2024 Best Paper Award” for research and review articles published in Vaccines from 1 January 2022 to 31 December 2022. Two reviews and two research articles will receive an award each. The papers will be selected after a thorough evaluation by the journal Award Committee led by the Editor-in-Chief, Prof. Dr. Ralph A. Tripp.
The Prize for Each Winner:
– Two review awards: CHF 400 and a chance to publish a paper free of charge in Vaccines in 2024 after peer review;
– Two research article awards: CHF 500 and a chance to publish a paper free of charge in Vaccines in 2024 after peer review;
– Each winner will also receive an electronic certificate.
The winners will be announced on the journal website in March 2024.
Kind regards,
Vaccines Editorial Office
Vaccines 2024 Best Paper Award
Eligibility and Requirements
– Papers published in Vaccines from 1 January 2022 to 31 December 2022;– Open to all career levels;
– Both regular and Special Issue submissions will be considered.
Selection Criteria
The papers will be selected by the journal Award Committee according to the following criteria:– Scientific merit and broad impact;
– Originality of the research objectives and/or the ideas presented;
– Creativity of the study design or uniqueness of the approaches and concepts;
– Clarity of presentation;
– Citations and downloads.
Past Winners
Year:
Winner
Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic
Willingness to Receive COVID-19 Vaccination in Japan
Vaccines 2021, 9(1), 48; https://doi.org/10.3390/vaccines9010048 - 14 Jan 2021
Nanomaterial Delivery Systems for mRNA Vaccines
Vaccines 2021, 9(1), 65; https://doi.org/10.3390/vaccines9010065 - 19 Jan 2021
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
Vaccines 2021, 9(4), 359; https://doi.org/10.3390/vaccines9040359 - 08 Apr 2021
